Alterations in cathepsin H activity and protein patterns in human colorectal carcinomas

British Journal of Cancer

Volumn 82, Issue 7, 2000, Pages 1317-1326

  Del Re, E C ^a   Shuja, S ^a   Cai, J ^a   Murnane, M J ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cathepsin H; Colorectal cancer; Cysteine proteinases

Indexed keywords

CATHEPSIN B; CATHEPSIN H; CATHEPSIN L; PROTEINASE;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034015358     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.1098     Document Type: Article

References (49)

1. Barrett AJ, Kembhavi AA, Brown MA, Kirschke CG, Tamai M and Hanada K (1982) L-trans-epoxysuccinyl-leucylamido (4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem J 201: 189-198
2. Breivnik J, Lothe RA, Meling GI, Rognum TO, Borresen-Dale A and Gaudernack G (1997) Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factors. Int J Cancer 74: 664-669
3. Breivnik J, Meling GI, Spurkland A, Rognum TO and Gaudernack G (1994) K-ras mutation in colorectal cancer: relations to patient age, sex and tumour location. Br J Cancer 69: 367-371
4. Budinha M, Strojan P, Smid L, Skrk J, Vrhovec I, Zupevc A, Rudolf Z, Zargi M, Krasovec M, Svetic B, Kopitar-Jerala N and Kos J (1996) Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefins A and B in head and neck carcinoma. Biol Chem Hoppe-Seyler 377: 385-390
5. Chapman HA, Riese RJ and Shi GP (1997) Emerging roles for cysteine proteases in human biology. Ann Rev Physiol 59: 63-88
6. Claus V, Jahraus A, Tjelle T, Berg T, Kirschke H, Faulstich H and Griffiths G (1998) Lysosomal enzyme trafficking between phagosomes, endosomes and lysosomes in J774 macrophages. Enrichment of cathepsin H in early endosomes. J Biol Chem 272: 9842-9851
7. Dawson-Saunders B and Trapp RG (1994) Basic and Clinical Biostatistics. Appleton and Lange: Norwalk, CT
8. Deans GT, Parks TG, Rowlands BJ and Spence RAJ (1992) Prognostic factors in colorectal cancer, Br J Surg 79: 608-613
9. Duffy MJ (1992) The role of proteolytic enzymes in cancer invasion and metastasis. Clin Exp Met 10: 145-155
10. Dukes CE (1932) The classification of the cancer of the rectum. J Pathol Bacter 35: 323-332
11. Fu YF, Nishinaka T, Yokoyama K and Chiu R (1998) A retinoblastoma susceptibility gene product, RB, targeting protease is regulated through the cell cycle FEBS Lett 421: 89-93
12. Gabrijelcic D, Svetic B, Spaic D, Skrk J, Bidinha M, Dolenc I, Popovic T, Cotic V and Turk V (1992) Cathepsins B, H and L in human breast carcinoma. Eur J Clin Chem Clin Biochem 30: 69-74
13. Guncar G, Podobnik M, Pungercar J, Strukelj B, Turk V and Turk D (1998) Crystal structure of porcine cathepsin H determined at 2.1 Å resolution: location of the mini-chain C-terminal carboxyl group defines cathepsin H aminopeptidase function. Structure 6: 51-61
14. Hartz PA and Wilson PD (1997) Functional defects in lysosomal enzymes in autosomal dominant polycystic kidney disease (ADPKD): abnormalities in synthesis, molecular processing, polarity and secretion. Biochem Mol Med 60: 8-26
15. Iacobuzio-Donahue C, Cai J, Noguiera C, Shuja S, Kim K and Murnane MJ (1996) Correlation of increased cathepsin B expression with p53 loss of heterozygosity at the transition from colorectal adenoma to carcinoma. Proc Am Ass Cancer Res 37: 95
16. Iacobuzio-Donahue CA, Shuja S, Cai J, Peng, and Murnane MJ (1997) Elevations of cathepsin B protein content and enzyme activity occur independently of glycosylation during colorectal tumor progression. J Biol Chem 272: 29190-29199
17. Johnson GD and Hersh LB (1990) Studies on the subsite specificity of the rat brain puromycin-sensitive aminopeptidase. Arch Biochem Biophys 276: 305-309
18. Kageshita T, Yoshii A, Kimura T, Maruo K, Ono T, Himeno M and Nishimura Y (1995) Biochemical and immunohistochemical analysis of cathepsins B, H, L and D in human melanocytic tumors. Arch Dermatol Res 287: 266-272
19. Katunuma N and Kominami E (1995) Structure, properties, mechanisms, and assays of cysteine protease inhibitors: cystatins and E-64 derivatives. Methods Enzymol 251: 382-397
20. Keppler D, Fondaneche MC, Dalet-Fumaron V, Pagano M and Burtin P (1988) Immunohistochemical and biochemical study of a cathepsin B proteinase in human colonic cancers. Cancer Res 48: 6855-6862
21. Kim K, Cai J, Shuja S, Kuo T and Murnane MJ (1998) Presence of activated ras correlates with increased cysteine proteinase activities in human colorectal carcinomas. Int J Cancer 79: 324-333
22. Kirschke H, Barrett AJ and Rawlings ND (1998) Lysosomal Cysteine Proteinases. Oxford University Press: New York
23. Kos J, Smid A, Krasovec M, Svetic B, Lenarcic B, Vrhovec I, Skrk J and Turk V (1995) Lysosomal proteases cathepsins D, B, H, L and their inhibitors steftns A and B in head and neck cancer. Biol Chem Hoppe-Seyler 376: 401-405
24. Kos J, Stabuc B, Schweiger A, Krasovec M, Cimerman N, Kopitar-Jerala N and Vrhovec I (1997) Cathepsins B, H and L and their inhibitors stefin A and cystatin C in sera of melanoma patients. Clin Cancer Res 3: 1815-1822
25. Lafuse WP, Brown D, Castle L and Zwilling BS (1995) IFN-gamma increases cathepsin H mRNA levels in mouse macrophages. J Leukoc Biol 57: 663-669
26. Lenz HJ, Danenberg KD, Leichman CG, Florentine B, Johnston PG, Groshen S, Zhou L, Xiong YP, Danenberg PV and Leichman LP (1998) p53 and thymidilate synthase expression in untreated stage II colon cancer: associations with recurrence, survival, and site. Clin Cancer Ses 4: 1277-1234
27. Leto G, Tumminiello FM, Pizzolanti G, Montalto G, Soresi M, Carroccio A, Ippolito S and Gebbia N (1997) Lysosomal aspartic and cysteine proteinases serum levels in patients with pancreatic cancer or pancreatitis. Pancreas 14: 22-27
28. Liefers GJ, Cleton-Jansen AM, van de Velde CJH, Hermans J, van Krieken JHJM, Cornelisse CJ and Tollenaar AEM (1998) Micrometastases and survival in stage II colorectal cancer. N Engl J Med 339: 223-228
29. Liotta LA and Steuer-Stevenson WG (1991) Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 51: 5054-5059
30. Lowry O, Rosebrough NJ, Farr AL and Randall RJ (1951) Protein measurements with the folin phenol reagent. J Biol Chem 193: 265-275
31. Mathur PP. Grima J, Mo MY, Zhu LJ, Aravindan GR, Calcagno K, O'Bryan M, Chung S, Mruk D, Lee WM, Silvestrini B and Cheng CY (1997) Differentia! expression of multiple cathepsin mRNAs in the rat testis during maturation and following Ionidamine induced tissue restructuring. Biochem Molec Biol Intern 42: 217-233
32. Mithofer K, Fernandez-del Castillo C, Rattner D and Warshaw AL (1998) Subcellular kinetics of early trypsinogen activation in acute rodent pancreatitis, Am J Physiol 274: G71-79
33. Nishimura Y and Kato K (1987) Identification of latent procathepsin H in microsomal lumen: characterization of protcolytic processing and enzyme activation. Arch Biochem Biophys 260: 712-718
34. Nishimura Y, Tsuji H, Sato H, Amano J and Himeno M (1995) Biochemical properties and intracellular processing of lysosomal cathepsin B and H. Biol Pharm Bull 18: 829-836
35. Nitatori T, Sato N, Kominami E and Uchiyama Y (1996) Participation of cathepsins B, H and L in perikaryal condensation of CA1 pyramidal neurons undergoing apoptosis after brief ischemia. In: Intracellular Protein Catabolism, Suzuki K and Bond J (eds), pp. 177-185. Plenum Press: New York
36. Paciucci R, Berrozpe G, Tora' M, Navarro E, Garcia de Herreros A and Real FX (1996) Isolation of tissue-type plasminogen activator, cathepsin H, and non-specific cross-reacting antigen from SK-PC-1 pancreas cancer cells using subtractive hybridization. FEBS Lett 385:72-76
37. Rubin E and Farber JL (1994) Pathology, JB Lippincott: Philadelphia
38. Schwartz MK (1995) Tissue cathepsins as tumor markers. Clin Clin Acta 237: 67-78
39. Schwartz WN and Barrett AJ (1980) Human cathepsin H Biochem J 191: 487-497
40. Sheahan K, Shuja S and Murnane MJ (1989) Cysteine protease activities and tumor development in human colorectal carcinomas. Cancer Res 49: 3809-3814
41. Shuja S, Sheahan K and Murnane MJ (1991) Cysteine endopeptidase activity levels in normal human tissues, colorectal adenomas and carcinomas, Int J Cancer 49: 341-346
42. Sivaparvathi M, Sawaya R, Gokaslan ZL, Rao JS and Chintala SK (1996) Expression and the role of cathepsin H in human glioma progression and invasion. Cancer Lett 107: 161-167
43. Taniguchi K, Tomita M, Kominami E and Uchiyama Y (1993) Cysteine proteinases in rat dorsal root ganglion and spinal cord, with special reference to the colocalization of these enzymes with calcitonin gene-related peptide in lysosomes. Brain Res 601: 143-153
44. Towbin H, Staehelin J and Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4353
45. Tsushima H, Ueki A, Matsuoka Y, Mihara H and Hopsu-Havu V (1991) Characterization of a cathepsin H-like enzyme from a melanoma cell line. Int J Cancer 48: 726-732
46. Turk B, Turk V and Turk D (1997) Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors. Biol Chem 378: 141-150
47. Turnbull RB, Kyle K, Watson FR and Spratt J (1967) Cancer of the colon: the influence of the no-touch isolation technique on survival rales. Ann Surg 166: 420-427
48. Waguri S, Sato N, Wanatabe T, Ishidoh K, Kominami E, Sato K, and Uchiyama Y (1995) Cysteine proteinases in GH4C1 cells, a rat pituitary tumour cell line, are secreted by the constitutive and regulated secretory pathways. Eur J Cell Biol 67: 308-318
49. Wolmark N, Fisher ER, Wienand HS, Fisher B (1984) The relationship of depth of penetration and tumor size to the number of positive nodes in Dukes' C colorectal cancer. Cancer 53: 2707-2712